Oncology PracticeVIDEO: Adding docetaxel up front improved survival in prostate cancer by more than a year June 2, 2014Genitourinary Cancer
Oncology PracticeDrug combo extends survival by more than 1 year in metastatic prostate cancer patientsJune 2, 2014Genitourinary Cancer
Oncology PracticeCircumcision may cut prostate cancer risk in black menMay 29, 2014Genitourinary Cancer
Oncology PracticeASCO 2014: Dr. Walter M. Stadler gives his top picks in genitourinary research May 27, 2014Genitourinary Cancer
The Journal of Community and Supportive OncologyPSA flare after initiation of abiraterone acetateMay 27, 2014Genitourinary Cancer
Oncology Practice4Kscore test may reduce unnecessary prostate biopsiesMay 22, 2014Genitourinary Cancer
Oncology PracticeClinical data support earlier PSA testing in black menMay 21, 2014Genitourinary Cancer
Oncology PracticeMidlife PSA measure predicted lethal prostate cancerMay 20, 2014Genitourinary Cancer
Oncology PracticeRegistry data: No increase in prostate cancer risk with long-term TRTMay 20, 2014Genitourinary CancerPreventive Care
Oncology PracticeDelaying ADT for PSA-only prostate cancer relapse appears safeMay 15, 2014Genitourinary Cancer
Oncology PracticeVitamin D deficiency predicts aggressive prostate cancerMay 1, 2014Genitourinary Cancer
Oncology PracticeChronic inflammation linked to high-grade prostate cancerApril 18, 2014Genitourinary Cancer
The Journal of Community and Supportive OncologyHealth behaviors among testicular cancer survivorsApril 17, 2014Genitourinary Cancer
